Ensysce Biosciences, Inc. (ENSC) vs Lucyd, Inc (LUCY)
A side-by-side comparison of Ensysce Biosciences, Inc. and Lucyd, Inc across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ENSC
Ensysce Biosciences, Inc.
$0.42HealthcareDelayed quote: Oct 6, 2026, 11:30 AM EDT
LUCY
Lucyd, Inc
$0.93HealthcareDelayed quote: Oct 6, 2026, 11:26 AM EDT
Total return — ENSC vs LUCY
growth of $100 · dividends reinvested · last 4yENSC -100.0% (-87.6%/yr)LUCY -99.2% (-70.5%/yr)LUCY compounded faster over this window
Log scale — wide-divergence pair
ENSC LUCY
ENSC vs LUCY: by the numbers
- •ENSC is the larger company ($6M vs $6M market cap).
- •Both run net losses; LUCY's is the smaller (-225.28% vs -1084.23% net margin).
Metrics side by side
Valuation
| Metric | ENSC | LUCY |
|---|---|---|
| P/S ratio | 5.55 | 1.72 |
| P/B ratio | N/A | 0.85 |
Profitability
| Metric | ENSC | LUCY |
|---|---|---|
| Gross margin | 0.00% | 22.79% |
| Operating margin | 0.00% | -319.16% |
| Net margin | -1084.23% | -225.28% |
| ROE | N/A | -111.42% |
| ROIC | N/A | -122.15% |
Growth (annualized)
| Metric | ENSC | LUCY |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 64.52% |
| Total return CAGR (5Y) | -86.22% | N/A |
Go deeper
Dig into the metrics
Ensysce Biosciences ROELucyd ROEEnsysce Biosciences operating marginLucyd operating marginEnsysce Biosciences revenue growthLucyd revenue growthEnsysce Biosciences free cash flowLucyd free cash flow
Ensysce Biosciences & Lucyd appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.